What weight loss to expect in your first month on Wegovy

Step 1: the 0.25 mg starter week, why modest results are the point

Your first pen contains 0.25 mg weekly doses. Many people expect this dose to work like a full-strength medicine and feel frustrated when the scales barely shift. It won't, and that's by design. The starter dose exists to let your gut adapt to semaglutide, slowing gastric emptying and reducing appetite more gradually, which keeps nausea manageable while your system adjusts.

Most people do notice some appetite change in week one or two (meals feel filling sooner, the urge to snack quietens slightly) but measurable weight loss at this stage is usually small. The Wegovy treatment overview explains the full titration pathway, which runs from 0.25 mg through to the 2.4 mg maintenance dose over roughly four to five months.

The practical upshot: if your first weigh-in at the end of month one shows 1–2 kg gone, that is not a sign the medicine isn't working, and our guide to one month Wegovy weight loss results explains in detail why that figure is a sign the medicine is doing exactly what the licensed schedule intends.

Step 2: what the trial data shows for the early weeks

The STEP 1 trial (published in the New England Journal of Medicine) followed 1,961 adults with obesity or overweight and at least one weight-related condition over 68 weeks. The average weight loss by week 68 at 2.4 mg was around 15%. Published analysis of the trial's early time-points consistently shows the loss curve is gentlest in the first four to eight weeks, steepens through months two to five as the dose rises, and levels off at or after maintenance.

Separately, the higher 7.2 mg dose (now MHRA-approved as a dedicated single-dose pen) produced approximately 20.7% average weight loss over 72 weeks in trials, narrowing the gap with tirzepatide. If you want to understand how results compare across monthly milestones over a longer timeline, the breakdown covers what the data shows at 3, 6 and 12 months.

One misconception worth addressing: some people assume that if the first month produces little visible change, the medicine is not absorbing or is somehow fake. In reality, the slow start is pharmacological, not a quality problem. Genuine semaglutide from a licensed UK pharmacy simply takes time to build its effect.

Step 3: the other factors that shape your first-month number

The trial figure is a mean. Around it sits a wide spread, some participants lost more in month one, others less. Several things drive that variation.

Gastrointestinal side effects (nausea, loose stools, indigestion) are most common in the early weeks and can temporarily reduce appetite, sometimes producing slightly faster early loss in people who tolerate the dose well, or, if severe, leading to reduced intake of fluids and food in ways that don't reflect true fat loss. The NHS semaglutide patient information page lists what to expect and which symptoms need prompt attention.

Baseline diet and activity matter too. People who make concurrent changes to protein intake and movement tend to see better early numbers. Muscle mass, hydration and sodium intake all influence what the scales show on any given day. A prescriber or dietitian is the right person to help you build the lifestyle side of treatment, our FAQs cover what the clinical team discusses at review.

For a closer look at how results typically develop after that initial period, the three-month Wegovy evidence page picks up where this one leaves off.

Step 4: what to do (and not do) with a quiet first month

The most useful thing you can do at week four is not to compare yourself to a forum post. Compare yourself to the licensed schedule: are you tolerating 0.25 mg, eating when genuinely hungry and staying hydrated? If yes, the process is on track.

Do not adjust your own dose timing or skip ahead to the next strength without clinical input. Titration decisions belong with your prescriber, who reviews your progress and any side effects before each step up. If you're on a private prescription and want to understand what the next months may look like, the six-month results page gives the evidence-backed picture for that stage. And if cost context is on your mind, the Wegovy pricing guide sets out what private treatment typically involves in the UK.

If you haven't yet started and are weighing up whether Wegovy is the right route for you, check your eligibility with our prescribers, it's a free consultation, reviewed by a GPhC-registered Independent Prescriber the same day.